| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
114 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | PAHC Phibro Animal Health Corporation | BENDHEIM JACK | President and CEO | Sell | 21,120 | $55.21 | $1,166,104.50 | -4.8% | |
| Mar 20, 2026 | EOLS Evolus, Inc. | Avelar Rui | See Remarks | Sell | 3,119 | $4.75 | $14,815.25 | -0.7% | |
| Mar 20, 2026 | EOLS Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Sell | 13,669 | $4.75 | $64,929.12 | -2.2% | |
| Mar 18, 2026 | COLL Collegium Pharmaceutical, Inc. | Dieter David | EVP & General Counsel | Sell | 13,976 | $34.92 | $488,099.22 | -15.4% | |
| Mar 16, 2026 | UTHR United Therapeutics Corporation | ROTHBLATT MARTINE A | Chairperson & CEO | Sell | 9,500 | $537.81 | $5,109,148.28 | -16.5% | |
| Mar 13, 2026 | ANIP ANI Pharmaceuticals, Inc. | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $72.62 | $36,310.00 | -0.6% | |
| Mar 13, 2026 | ANIP ANI Pharmaceuticals, Inc. | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,162 | $71.64 | $226,525.68 | -3.3% | |
| Mar 11, 2026 | UTHR United Therapeutics Corporation | ROTHBLATT MARTINE A | Chairperson & CEO | Sell | 360 | $532.13 | $191,566.01 | -3.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.